Aldeyra Therapeutics, Inc. (ALDX) Q2 2019 Earnings Conference Call August 08, 2019, 08:00 ET Company Participants Joshua Reed - CFO Todd Brady - CEO, President & Director Conference Call Participants Victor Rusu - Citigroup Esther Hong - Janney Montgomery Scott I-Eh J...

Part 1 of Adaptive Phase 3 RENEW Trial in Dry Eye Disease Expected to be Completed in Fourth Quarter 2019 Meeting with FDA Scheduled in Fourth Quarter 2019 to Confirm Design of Second Phase 3 Trial in Allergic Conjunctivitis Initiation of the Adaptive Phase 3 GUARD Trial of AD...

Aldeyra Therapeutics, Inc . ( Nasdaq: ALDX ) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced that the Company will host a conference call on Thursday, August...